PeptideDB

Sari 59-801

CAS No.: 80565-58-8

Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin rel
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).
In vivo 在禁食小鼠中,2小时降糖ED25为110 mg/kg;同时,血浆胰岛素水平有所上升,其ED50为47 mg/kg。在禁食大鼠中,口服Sari 59-801 2小时后观察到显著的降糖活性(ED25 = 86 mg/kg),而100 mg/kg的剂量可使血浆胰岛素水平提高62%。
Synonyms Sari-59-801
molecular weight 313.39
Molecular formula C18H23N3O2
CAS 80565-58-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 65 mg/mL (207.41 mM)
References 1. Hanson RL, Isaacson CM. Stimulation of insulin secretion from isolated rat islets by SaRI 59-801. Relation to cAMP concentration and Ca2+ uptake. Diabetes. 1985 Jul;34(7):691-5. PubMed PMID: 2408949. 2. Hanson RL, Isaacson CM, Boyajy LD. Stimulation of insulin secretion from isolated rat islets by SaRI 59-801. Diabetes. 1985 Jun;34(6):548-52. PubMed PMID: 3924691.